Navigation Links
Sigma-Aldrich Announces Appointment of Magnus Borg as Vice President and Chief Information Officer (CIO)
Date:8/18/2010

ST. LOUIS, Aug. 18 /PRNewswire-FirstCall/ -- Sigma-Aldrich® Corporation (Nasdaq: SIAL) is pleased to announce that Magnus Borg has been named Vice President and Chief Information Officer, effective August 16, 2010. In his new role, Borg will lead the Company's global information systems function and will report to Rakesh Sachdev, Sr. Vice President, Chief Financial Officer and Chief Administrative Officer.

Borg (age 50) brings over two decades of senior IT management experience to Sigma-Aldrich, including significant operations and sales development experience in the U.S. and abroad.  Born and raised in Sweden, he has enjoyed a successful career with leading global companies including Ericsson, SEB Bank, Svensk Bilprovning and Safety-Kleen. He held the CIO posts for Ericsson North America and Safety-Kleen.  Borg's wealth of relevant global experience and diverse technical knowledge are expected to help him accelerate the continuous improvement of Sigma-Aldrich's information technology and customer service capabilities to most fully meet customer and shareholder needs.

"We're excited to welcome Magnus to Sigma-Aldrich," said Rakesh Sachdev, CFO and CAO.  "His experience as a 'business-minded' global IT professional should enhance our leadership position in the life science and high technology markets we serve. Magnus has an impressive track record of success, directly contributing to top-line growth in his previous roles, and his innovative approach is expected to help drive Sigma-Aldrich's business strategy. I'm excited to work closely with him as we continue to enhance our Company's capability to be the trusted partner of choice for our customers."

Borg and his family will be relocating to St. Louis, the world headquarters of Sigma-Aldrich.

Cautionary Statement: This release contains forward-looking statements relating to future performance, goals, strategic actions and initiatives and similar intentions and beliefs, including phrases "are expected", "is expected", "help accelerate", "continuous improvement", "enhance our leadership position" and other statements regarding the Company's expectations, goals, beliefs, intentions and the like regarding future sales and other matters. These statements are based on assumptions regarding Company operations, investments and acquisitions and conditions in the markets the Company serves. The Company believes these assumptions are reasonable and well founded. The forward looking statements in this release are subject to risks and uncertainties, including, among others, certain economic, political and technological factors referred to in the Company's current Form 10-K on file with the Securities and Exchange Commission.

About Sigma-Aldrich: Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development and as key components in pharmaceutical, diagnostic and other high technology manufacturing. The Company has customers in life science companies, university and government  institutions, hospitals, and in industry. Over one million scientists and technologists use its products. Sigma-Aldrich operates in 40 countries and has 7,600 employees providing excellent service worldwide. Sigma-Aldrich is committed to Accelerating Customer Success through Innovation and Leadership in Life Science, High Technology and Service. For more information about Sigma-Aldrich, please visit its award-winning Web site at http://www.sigma-aldrich.com.

Sigma-Aldrich is a registered trademark of Sigma-Aldrich Biotechnology L.P. and Sigma-Aldrich Co.


'/>"/>
SOURCE Sigma-Aldrich Corporation
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sigma-Aldrich Corporation to Present at the Bairds 2010 Growth Stock Conference on Thursday, May 20, 2010
2. Sigma-Aldrich (Nasdaq: SIAL) Announces Executive Management Changes: Retirement of David Julien and Promotion of Joseph Porwoll
3. Sigma-Aldrich to Present at the Bank of America Merrill Lynch 2010 Health Care Conference on Wednesday, May 12, 2010
4. Sigma-Aldrich(R) Focuses on Biology With Launch of New Life Science Brand Platform
5. Sigma-Aldrich to Present at the NASDAQ OMX 23rd Investor Program on Tuesday, December 1, 2009
6. Sigma-Aldrich (Nasdaq: SIAL) Declares Quarterly Dividend
7. Sigma-Aldrich(R) and Sangamo BioSciences Announce Major Expansion of ZFP Technology License Agreement
8. Sigma-Aldrich Elects George M. Church as Director
9. Sigma-Aldrich to Present at the UBS Global Life Sciences Conference on Monday, September 21, 2009
10. BioLife Solutions Announces HypoThermosol(R) and CryoStor(TM) Distribution Agreement With Sigma-Aldrich
11. Sigma-Aldrich to Present at the Thomas Weisel Healthcare Conference on Thursday, September 10, 2009
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... Feb. 23, 2017 ... except per share data, unaudited)Three Months Ended December 31,Twelve ... Revenue $       ... 1,117$   89026%Aldurazyme Net Product Revenue ... 906538%34823946%Naglazyme Net Product Revenue  756025%297303(2)%Vimizim ...
(Date:2/23/2017)... -- In Atlanta, it seems everyone has a chance to express ... an expressive and dynamic community unlike any other. The businesses ... it. With their newest salon in ... carry on that tradition with a unique, fresh approach to ... is the newest of 13 nationwide locations, each of them ...
(Date:2/23/2017)... ... February 23, 2017 , ... ... evaluation of multiple immunoassay-based threat detection technologies by researchers from the Pacific ... biosensor threat detection technology was found to have the best level of ...
(Date:2/23/2017)... -- Capricor Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological ... Linda Marbán, Ph.D, president and chief executive officer, is scheduled ... Cowen and Company 37th Annual Health Care Conference Tuesday, ... MA 29th Annual ROTH Conference ... ET) Dana Point, CA ...
Breaking Biology Technology:
(Date:2/2/2017)... 2, 2017   TapImmune, Inc. (NASDAQ: ... specializing in the development of innovative peptide and ... cancer and metastatic disease, announced today it has ... of a second clinical lot of TPIV 200, ... alpha. The manufactured vaccine product will be used ...
(Date:2/2/2017)... 1, 2017  Central to its deep commitment ... worldwide, The Japan Prize Foundation today announced the ... pushed the envelope in their respective fields of ... scientists are being recognized with the 2017 Japan ... only contribute to the advancement of science and ...
(Date:1/31/2017)... 2017  Spero Therapeutics, LLC, a biopharmaceutical company ... of bacterial infections, today announced it has acquired ... Pro Bono Bio Ltd (PBB) to bolster its ... forms of Gram-negative bacteria.   The assets acquired have ... PBB group company. "The acquisition of ...
Breaking Biology News(10 mins):